Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
This study is ongoing, but not recruiting participants.
Study NCT00003427 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anal Cancer
Colorectal Cancer
Esophageal Cancer
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Gastric Cancer
Gastrointestinal Carcinoid Tumor
Liver Cancer
Pancreatic Cancer
Small Intestine Cancer
Additional conditions recognized in this trial
Anus Neoplasms
Bile Duct Neoplasms
Carcinoid Tumor
Colorectal Neoplasms
Duodenal Neoplasms
Esophageal Diseases
Esophageal Neoplasms
Gallbladder Neoplasms
Gastrointestinal Neoplasms
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Liver Neoplasms
Malignant Carcinoid Syndrome
Pancreatic Neoplasms
Stomach Neoplasms
More general conditions related to this trial
Adenocarcinoma
Anus Diseases
Bile Duct Diseases
Biliary Tract Diseases
Biliary Tract Neoplasms
Carcinoma
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Gallbladder Diseases
Gastrointestinal Diseases
Head and Neck Neoplasms
Ileal Diseases
Intestinal Diseases
Jejunal Diseases
Liver Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Pancreatic Diseases
Rectal Diseases
Rectal Neoplasms
Stomach Diseases
Interventions listed in this trial
irinotecan hydrochloride
oxaliplatin
Additional drug interventions recognized in this trial
Camptothecin
Irinotecan
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
